Faron Pharmaceuticals Oy (HEL:FARON)
Finland · Delayed Price · Currency is EUR 2.085
-0.155 (-6.92%)
At close: Nov 25, 2025
Faron Pharmaceuticals Oy Statistics
Total Valuation
HEL:FARON has a market cap or net worth of EUR 237.22 million. The enterprise value is 245.90 million.
| Market Cap | 237.22M |
| Enterprise Value | 245.90M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 113.90M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +55.54% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 21.54% |
| Owned by Institutions (%) | 8.42% |
| Float | 82.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -14.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.95 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89
| Current Ratio | 1.89 |
| Quick Ratio | 1.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.68% |
| Return on Invested Capital (ROIC) | -119.01% |
| Return on Capital Employed (ROCE) | -230.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -967,125 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -41,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.90% in the last 52 weeks. The beta is 1.24, so HEL:FARON's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +10.90% |
| 50-Day Moving Average | 2.17 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 47.90 |
| Average Volume (20 Days) | 318,886 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.29M |
| Pretax Income | -30.99M |
| Net Income | -30.95M |
| EBITDA | -19.10M |
| EBIT | -19.29M |
| Earnings Per Share (EPS) | -0.29 |
Balance Sheet
The company has 13.53 million in cash and 22.41 million in debt, giving a net cash position of -8.88 million.
| Cash & Cash Equivalents | 13.53M |
| Total Debt | 22.41M |
| Net Cash | -8.88M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -16.25M |
| Book Value Per Share | -0.15 |
| Working Capital | 6.98M |
Cash Flow
| Operating Cash Flow | -24.69M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEL:FARON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.54% |
| Shareholder Yield | -55.54% |
| Earnings Yield | -13.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |